Title:
CRYSTAL FORM OF PURINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/274310
Kind Code:
A1
Abstract:
A crystal form of substituted purine derivatives and pharmaceutical compositions thereof, preparation methods, and uses for preparing a DNA-PK inhibitor are related to. Specifically, a crystal form of a compound represented by formula (A), pharmaceutical compositions thereof, preparation methods, and uses for preparing a DNA-PK inhibitor are related to.
More Like This:
Inventors:
XU XUEZHEN (CN)
LEI FEIQUAN (CN)
ZHU DAN (CN)
HE LVXUE (CN)
WEI YONGGANG (CN)
SUN YI (CN)
LEI FEIQUAN (CN)
ZHU DAN (CN)
HE LVXUE (CN)
WEI YONGGANG (CN)
SUN YI (CN)
Application Number:
PCT/CN2022/102452
Publication Date:
January 05, 2023
Filing Date:
June 29, 2022
Export Citation:
Assignee:
CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D519/00; A61K31/522; A61P35/00; C07D473/32
Domestic Patent References:
WO2021136463A1 | 2021-07-08 | |||
WO2021104277A1 | 2021-06-03 | |||
WO2019238929A1 | 2019-12-19 | |||
WO2018114999A1 | 2018-06-28 |
Foreign References:
CN114573605A | 2022-06-03 |
Other References:
GOLDBERG FREDERICK W., FINLAY M. RAYMOND V., TING ATTILLA K. T., BEATTIE DAVID, LAMONT GILLIAN M., FALLAN CHARLENE, WRIGLEY GAIL L: "The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5- a ]pyridin-6-yl)amino]-9-(tetrahydro-2 H -pyran-4-yl)-7,9-dihydro-8 H -purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 63, no. 7, 9 April 2020 (2020-04-09), US , pages 3461 - 3471, XP055826430, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.9b01684
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
Previous Patent: MAP GENERATION METHOD AND APPARATUS, AND MAP USAGE METHOD AND APPARATUS
Next Patent: BATTERY PACK AND ELECTRICAL DEVICE
Next Patent: BATTERY PACK AND ELECTRICAL DEVICE